IBDEI2W3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48518,1,4,0)
 ;;=4^I69.844
 ;;^UTILITY(U,$J,358.3,48518,2)
 ;;=^5133578
 ;;^UTILITY(U,$J,358.3,48519,0)
 ;;=I69.241^^216^2407^74
 ;;^UTILITY(U,$J,358.3,48519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48519,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff right dom side
 ;;^UTILITY(U,$J,358.3,48519,1,4,0)
 ;;=4^I69.241
 ;;^UTILITY(U,$J,358.3,48519,2)
 ;;=^5007469
 ;;^UTILITY(U,$J,358.3,48520,0)
 ;;=I69.242^^216^2407^75
 ;;^UTILITY(U,$J,358.3,48520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48520,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff left dom side
 ;;^UTILITY(U,$J,358.3,48520,1,4,0)
 ;;=4^I69.242
 ;;^UTILITY(U,$J,358.3,48520,2)
 ;;=^5133574
 ;;^UTILITY(U,$J,358.3,48521,0)
 ;;=I69.243^^216^2407^76
 ;;^UTILITY(U,$J,358.3,48521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48521,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff r nondom side
 ;;^UTILITY(U,$J,358.3,48521,1,4,0)
 ;;=4^I69.243
 ;;^UTILITY(U,$J,358.3,48521,2)
 ;;=^5007470
 ;;^UTILITY(U,$J,358.3,48522,0)
 ;;=I69.244^^216^2407^77
 ;;^UTILITY(U,$J,358.3,48522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48522,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff l nondom side
 ;;^UTILITY(U,$J,358.3,48522,1,4,0)
 ;;=4^I69.244
 ;;^UTILITY(U,$J,358.3,48522,2)
 ;;=^5007471
 ;;^UTILITY(U,$J,358.3,48523,0)
 ;;=G35.^^216^2407^78
 ;;^UTILITY(U,$J,358.3,48523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48523,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,48523,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,48523,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,48524,0)
 ;;=G20.^^216^2407^79
 ;;^UTILITY(U,$J,358.3,48524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48524,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,48524,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,48524,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,48525,0)
 ;;=G21.4^^216^2407^80
 ;;^UTILITY(U,$J,358.3,48525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48525,1,3,0)
 ;;=3^Vascular parkinsonism
 ;;^UTILITY(U,$J,358.3,48525,1,4,0)
 ;;=4^G21.4
 ;;^UTILITY(U,$J,358.3,48525,2)
 ;;=^5003776
 ;;^UTILITY(U,$J,358.3,48526,0)
 ;;=I69.051^^216^2407^48
 ;;^UTILITY(U,$J,358.3,48526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48526,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,48526,1,4,0)
 ;;=4^I69.051
 ;;^UTILITY(U,$J,358.3,48526,2)
 ;;=^5007409
 ;;^UTILITY(U,$J,358.3,48527,0)
 ;;=I69.052^^216^2407^46
 ;;^UTILITY(U,$J,358.3,48527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48527,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,48527,1,4,0)
 ;;=4^I69.052
 ;;^UTILITY(U,$J,358.3,48527,2)
 ;;=^5007410
 ;;^UTILITY(U,$J,358.3,48528,0)
 ;;=I69.053^^216^2407^49
 ;;^UTILITY(U,$J,358.3,48528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48528,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,48528,1,4,0)
 ;;=4^I69.053
 ;;^UTILITY(U,$J,358.3,48528,2)
 ;;=^5007411
 ;;^UTILITY(U,$J,358.3,48529,0)
 ;;=I69.054^^216^2407^47
 ;;^UTILITY(U,$J,358.3,48529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48529,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,48529,1,4,0)
 ;;=4^I69.054
 ;;^UTILITY(U,$J,358.3,48529,2)
 ;;=^5007412
 ;;^UTILITY(U,$J,358.3,48530,0)
 ;;=I50.41^^216^2408^1
 ;;^UTILITY(U,$J,358.3,48530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48530,1,3,0)
 ;;=3^Acute combined systolic and diastolic (congestive) hrt fail
 ;;^UTILITY(U,$J,358.3,48530,1,4,0)
 ;;=4^I50.41
